Open AccessVulnerability to omega-3 deprivation in a mouse model of NMDA receptor hypofunction
Author(s) -
R. Islam,
Marc-Olivier Trépanier,
Marija Milenković,
Wendy Horsfall,
Ali Salahpour,
Richard P. Bazinet,
Amy J. Ramsey
Publication year - 2017
Publication title -
npj schizophrenia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.173
H-Index - 23
ISSN - 2334-265X
DOI - 10.1038/s41537-017-0014-8
Subject(s) - nmda receptor , vulnerability (computing) , neuroscience , omega , psychology , receptor , medicine , computer science , philosophy , computer security , linguistics
Several studies have found decreased levels of ω-3 polyunsaturated fatty acids in the brain and blood of schizophrenia patients. Furthermore, dietary ω-3 supplements may improve schizophrenia symptoms and delay the onset of first-episode psychosis. We used an animal model of NMDA receptor hypofunction, NR1KD mice, to understand whether changes in glutamate neurotransmission could lead to changes in brain and serum fatty acids. We further asked whether dietary manipulations of ω-3, either depletion or supplementation, would affect schizophrenia-relevant behaviors of NR1KD mice. We discovered that NR1KD mice have elevated brain levels of ω-6 fatty acids regardless of their diet. While ω-3 supplementation did not improve any of the NR1KD behavioral abnormalities, ω-3 depletion exacerbated their deficits in executive function. Omega-3 depletion also caused extreme mortality among male mutant mice, with 75% mortality rate by 12 weeks of age. Our studies show that alterations in NMDAR function alter serum and brain lipid composition and make the brain more vulnerable to dietary ω-3 deprivation.